FierceBiotech· @FierceBiotech · X·· 27 天前AI 评分38
AI 导读
经历FDA一段动荡时期后,CBER主任Karim Mikhail告诉Fierce,他专注于恢复稳定、重建士气并重新思考罕见病监管。"我不会躲起来,"他说。https://www.fiercebiotech.com/biotech/cber-director-karim-mikhail-tells-fierce-he-feels-people-deserve-leader-whos-present
正文
After a turbulent period at the FDA, CBER Director Karim Mikhail tells Fierce he's focused on restoring stability, rebuilding morale and rethinking rare disease regulation. "I'm not going to hide," he said. https://www.fiercebiotech.com/biotech/cber-director-karim-mikhail-tells-fierce-he-feels-people-deserve-leader-whos-present
来源:FierceBiotech · x.com